DANIEL GRIFFITH ANDERSON - 02 Jun 2021 Form 4 Insider Report for Sigilon Therapeutics, Inc.

Role
Director
Signature
/s/ Matthew Kowalsky, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
02 Jun 2021
Net transactions value
-$2,000,000
Form type
4
Filing time
04 Jun 2021, 16:15:17 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGTX Common Stock Sale $2,000,000 -200,000 -9% $10.00* 2,022,222 02 Jun 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.